Capitolis Liquid Global Markets LLC grew its position in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 28.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 738,022 shares of the company’s stock after buying an additional 164,222 shares during the quarter. Capitolis Liquid Global Markets LLC’s holdings in Procter & Gamble were worth $105,766,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Triodos Investment Management BV increased its position in Procter & Gamble by 7.3% during the 3rd quarter. Triodos Investment Management BV now owns 255,095 shares of the company’s stock worth $39,195,000 after purchasing an additional 17,400 shares in the last quarter. Gradient Investments LLC increased its position in Procter & Gamble by 12.8% during the 4th quarter. Gradient Investments LLC now owns 253,089 shares of the company’s stock worth $36,270,000 after purchasing an additional 28,777 shares in the last quarter. Fiera Capital Corp increased its position in Procter & Gamble by 20.3% during the 3rd quarter. Fiera Capital Corp now owns 53,128 shares of the company’s stock worth $8,163,000 after purchasing an additional 8,961 shares in the last quarter. Arete Wealth Advisors LLC acquired a new position in Procter & Gamble during the 3rd quarter worth approximately $3,776,000. Finally, Cibc World Market Inc. increased its position in Procter & Gamble by 40.6% during the 4th quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock worth $73,351,000 after purchasing an additional 147,701 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Trading Down 1.4%
PG opened at $150.39 on Thursday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The firm has a market capitalization of $350.20 billion, a price-to-earnings ratio of 21.99, a PEG ratio of 6.63 and a beta of 0.39. The company’s 50 day moving average price is $145.12 and its two-hundred day moving average price is $147.76.
Procter & Gamble Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Friday, April 24th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s payout ratio is presently 63.60%.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the stock. Raymond James Financial lowered their price objective on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a research report on Tuesday, April 14th. Royal Bank Of Canada lowered their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a research report on Thursday, April 9th. Jefferies Financial Group lowered their price objective on shares of Procter & Gamble from $179.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Morgan Stanley lowered their price objective on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Finally, Rothschild & Co Redburn lowered their price objective on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $160.78.
View Our Latest Stock Report on Procter & Gamble
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: PG’s Herbal Essences brand is launching a limited-edition Papaya + Citrus Strength collection with Love Island’s Amaya, a move aimed at younger consumers and designed to support brand relevance and sales momentum. Procter & Gamble (PG) Launches Herbal Essences Papaya And Citrus Line With Amaya
- Positive Sentiment: Procter & Gamble is expanding retail-media and co-marketing efforts through Albertsons, including an industry-first scripted branded entertainment model, which could strengthen consumer engagement and product visibility. Albertsons Media Collective Unveils Industry-First Branded Entertainment Model, Co-Developed with Procter & Gamble
- Positive Sentiment: PG has recently been trading higher relative to the market, reflecting investor interest in its defensive profile and stable earnings power. Procter & Gamble (PG) Advances While Market Declines: Some Information for Investors
- Neutral Sentiment: Coverage highlighting PG as a classic dividend and defensive stock reinforces its appeal to income-focused investors, but does not signal a new catalyst for the shares. 3 Dividend Stocks That Pay You More Every Single Year
- Negative Sentiment: One commentary argued that the stock may be a crowded defensive trade and suggested other cash-flow names may offer better upside, which could weigh on sentiment at the margin. Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
